Human mesenchymal stem cells promote growth of osteosarcoma: Involvement of interleukin-6 in the interaction between human mesenchymal stem cells and Saos-2-Reference-Cited by-同舟云学术

Human mesenchymal stem cells promote growth of osteosarcoma: Involvement of interleukin-6 in the interaction between human mesenchymal stem cells and Saos-2

Published:2010-09-28 Issue:12 Volume:101 Page:2554-2560
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:

Author:

Bian Zhen-Yu,Fan Qi-Ming,Li Gang,Xu Wen-Ting,Tang Ting-Ting

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1349-7006.2010.01731.x/fullpdf

Reference34 articles.

1. Putting tumours in context;Bissell;Nat Rev Cancer,2001

2. A role for the Wnt gene family in hematopoiesis: expansion of multilineage progenitor cells;Austin;Blood,1997

3. Haemopoietic stem cells and the problem of self-renewal;Dexter;Blood Cells,1984

4. Role of members of the Wnt gene family in human hematopoiesis;Van Den Berg;Blood,1998

5. Wnt proteins are lipid-modified and can act as stem cell growth factors;Willert;Nature,2003

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Extracellular matrix from hiPSC-mesenchymal progenitors modulates the three-lineage differentiation of human bone marrow stromal cells;European Cells and Materials;2024-04-02

2. The potential applications of artificially modified exosomes derived from mesenchymal stem cells in tumor therapy;Frontiers in Oncology;2024-01-04

3. Cell membrane-anchored and tumor-targeted IL-12 T-cell therapy destroys cancer-associated fibroblasts and disrupts extracellular matrix in heterogenous osteosarcoma xenograft models;Journal for ImmunoTherapy of Cancer;2024-01

4. Examining the Effects of Dasatinib, Sorafenib, and Nilotinib on Vascular Smooth Muscle Cells: Insights into Proliferation, Migration, and Gene Expression Dynamics;Diseases;2023-10-23

5. Effectiveness and safety of mesenchymal stem/stromal cell for radiation-induced hyposalivation and xerostomia in previous head and neck cancer patients (MESRIX-III): a study protocol for a single-centre, double-blinded, randomised, placebo-controlled, phase II study;Trials;2023-09-01